
USD
( 0.00%
At Close (As of Jan 1, 1970)
$1.23B
Market Cap
-
P/E Ratio
-4.32
EPS
$71.50
52 Week High
$7.76
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Total Assets | $557M |
| Total Current Assets | $390M |
| Cash And Cash Equivalents At Carrying Value | $159M |
| Cash And Short Term Investments | $159M |
| Inventory | $0 |
| Current Net Receivables | $5.9M |
| Total Non Current Assets | $166M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $71M |
| Intangible Assets Excluding Goodwill | $71M |
| Goodwill | $22M |
| Investments | - |
| Long Term Investments | $27M |
| Short Term Investments | $209M |
| Other Current Assets | $17M |
| Other Non Current Assets | - |
| Total Liabilities | $563M |
| Total Current Liabilities | $40M |
| Current Accounts Payable | $7.2M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $3.6M |
| Total Non Current Liabilities | $523M |
| Capital Lease Obligations | $15M |
| Long Term Debt | $51M |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $66M |
| Other Current Liabilities | $29M |
| Other Non Current Liabilities | $454M |
| Total Shareholder Equity | -$6.8M |
| Treasury Stock | - |
| Retained Earnings | -$1.1B |
| Common Stock | $2.9M |
| Common Stock Shares Outstanding | $49M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$183M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $13M |
| Capital Expenditures | $3.4M |
| Change In Receivables | - |
| Change In Inventory | $2.4M |
| Profit Loss | - |
| Cashflow From Investment | $163M |
| Cashflow From Financing | -$59M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$240M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
uniQure NV is an innovative gene therapy company headquartered in Amsterdam, Netherlands, dedicated to developing transformative treatments for genetic disorders and severe diseases. Utilizing its proprietary AAV-based gene therapy platform, the company aims to address significant unmet medical needs, particularly in areas such as hemophilia and neurodegenerative disorders. With a strong pipeline of product candidates and a commitment to advancing patient care through cutting-edge genetic therapies, uniQure is poised to play a leading role in the rapidly evolving gene therapy landscape.